Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.185 USD | +0.42% | -3.66% | -10.90% |
01-13 | Piper Sandler Reviews Tilray's Q2 | MT |
01-10 | Global markets live: Nvidia, Bank of America, Block, Holcim, Unicredit... |
Chart calendar Tilray Brands, Inc.
Upcoming events on Tilray Brands, Inc.
Past events on Tilray Brands, Inc.
2025-01-10 08:30 | Q2 2025 Earnings Call |
2025-01-10 07:00 | Q2 2025 Earnings Release |
2024-12-19 11:00 | Annual General Meeting |
2024-10-10 08:30 | Q1 2025 Earnings Call |
2024-10-10 07:00 | Q1 2025 Earnings Release |
2024-08-14 10:30 | CG Growth Conference |
2024-07-29 16:30 | Q4 2024 Earnings Call |
2024-07-29 16:05 | Q4 2024 Earnings Release |
2024-04-09 08:30 | Q3 2024 Earnings Call |
2024-04-09 07:00 | Q3 2024 Earnings Release |
2024-01-09 08:30 | Q2 2024 Earnings Call |
2024-01-09 07:00 | Q2 2024 Earnings Release |
2023-11-21 11:00 | Annual General Meeting |
2023-10-04 08:30 | Q1 2024 Earnings Call |
2023-10-04 07:00 | Q1 2024 Earnings Release |
2023-08-07 16:45 | Acquisition of Eight Beer and Beverage Brands From Anheuser-Busch by Tilray Brands Inc Call |
2023-07-26 08:30 | Q4 2023 Earnings Call |
2023-07-26 07:00 | Q4 2023 Earnings Release |
2023-04-10 17:00 | Q3 2023 Earnings Call |
2023-04-10 07:00 | Q3 2023 Earnings Release |
Annual results
Fiscal Period | May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 628 630 -0.23% | 627 598 4.8% | 789 783 0.74% | 896 | 947 | 1 012 |
EBITDA Million USD | Released Forecast Spread | 48,0 46,8 2.59% | 61,5 59,3 3.76% | 60,5 59,7 1.23% | 63,5 | 72,8 | 139 |
EBIT Million USD | Released Forecast Spread | -143 -175 18.52% | -108 -126 14.27% | -175 -171 -2.01% | -114 | -74,1 | 135 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -441 -20,7 -2025.84% | -1 450 -1 071 -35.36% | -249 -210 -18.48% | -142 | -71,5 | 42,0 |
Net income Million USD | Released Forecast Spread | -434 -42,0 -933.57% | -1 443 -1 212 -19.1% | -222 -217 -2.28% | -140 | -80,0 | -7,07 |
EPS USD | Released Forecast Spread | -0,90 -0,04 -1993.02% | -2,35 -2,01 -17.09% | -0,33 -0,32 -2.21% | -0,16 | -0,09 | -0,02 |
Announcement Date | 28/07/22 | 26/07/23 | 29/07/24 | - |
Quarterly results
Fiscal Period | November | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 184 154 19.63% | 177 174 1.54% | 194 195 -0.64% | 188 198 -5.04% | 230 227 1.14% | 200 221 -9.42% | 211 216 -2.49% | 214 | 275 | 227 | 230 | 229 | 271 |
EBITDA Million USD | Released Forecast Spread | 22,2 19,9 11.75% | 11,4 11,2 1.85% | 10,1 13,6 -25.58% | 10,2 13,7 -25.74% | 29,5 28,5 3.53% | 9,33 13,4 -30.47% | 9,02 12,3 -26.69% | 9,70 | 35,3 | 12,9 | 13,9 | 14,8 | 36,4 |
EBIT Million USD | Released Forecast Spread | -16,6 -22,7 27.01% | -34,4 -27,7 -23.88% | -41,8 -26,6 -57.22% | -82,1 -28,6 -186.92% | -16,5 -12,7 -30.38% | -36,6 -18,5 -97.85% | -42,2 -22,5 -87.74% | -28,7 | -1,36 | -25,5 | -24,4 | -25,5 | -2,35 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -112 -28,8 -287.22% | -48,6 -36,0 -35.17% | -49,6 -39,1 -26.83% | -108 -37,7 -185.88% | -43,0 -21,3 -101.9% | -33,8 -30,0 -12.58% | -83,2 -36,7 -126.79% | -39,0 | -12,0 | -38,5 | -38,8 | -38,9 | -13,4 |
Net income Million USD | Released Forecast Spread | -120 -27,8 -331.66% | -55,9 -34,4 -62.61% | -46,2 -38,5 -19.82% | -105 -38,4 -173.47% | -15,4 -20,4 24.71% | -34,7 -28,6 -21.34% | -85,3 -35,0 -143.8% | -35,4 | -13,6 | -30,0 | -30,3 | -30,3 | -10,5 |
EPS USD | Released Forecast Spread | -0,15 -0,04 -259.97% | -0,10 -0,05 -93.54% | -0,07 -0,06 -23.52% | -0,12 -0,05 -127.01% | -0,04 -0,02 -71.45% | -0,04 -0,05 20% | -0,10 -0,04 -150% | -0,04 | -0,02 | -0,03 | -0,03 | -0,03 | -0,01 |
Announcement Date | 26/07/23 | 04/10/23 | 09/01/24 | 09/04/24 | 29/07/24 | 10/10/24 | 10/01/25 | - | - | - | - | - | - |
Past sector events for Tilray Brands, Inc.
2025-01-10 07:00 | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
2025-01-10 04:09 | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 18:50 | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 05:25 | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
2025-01-08 03:17 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2024-12-10 11:45 | MEDINCELL S.A.: Q2 2025 Earnings Release |
2024-12-10 04:02 | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
2024-12-10 01:29 | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
2024-12-09 04:04 | SCINOPHARM TAIWAN, LTD.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TLRY Stock
- Calendar Tilray Brands, Inc.
MarketScreener is also available in this country: United States.
Switch edition